medroxyprogesterone has been researched along with Abnormality, Heart in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eibs, HG; Hägele, M; Spielmann, H | 1 |
| Carroad, E; Cukierski, M; Hendrickx, AG; Prahalada, S | 1 |
| Chemke, J; Katz, Z; Klinberg, M; Lancet, M; Mogilner, BM; Skornik, J | 1 |
3 other study(ies) available for medroxyprogesterone and Abnormality, Heart
| Article | Year |
|---|---|
Teratogenic effects of cyproterone acetate and medroxyprogesterone treatment during the pre- and postimplantation period of mouse embryos. I.
Topics: Abnormalities, Drug-Induced; Animals; Cleft Palate; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Dose-Response Relationship, Drug; Embryonic Development; Female; Fetal Death; Gestational Age; Heart Defects, Congenital; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Pregnancy; Respiratory System Abnormalities; Skull; Urinary Tract | 1982 |
Embryotoxicity of a single dose of medroxyprogesterone acetate (MPA) and maternal serum MPA concentrations in cynomolgus monkey (Macaca fascicularis).
Topics: Abnormalities, Drug-Induced; Adrenal Glands; Animals; Dose-Response Relationship, Drug; Female; Genitalia; Heart Defects, Congenital; Macaca fascicularis; Male; Maternal-Fetal Exchange; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy | 1985 |
Teratogenicity of progestogens given during the first trimester of pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Habitual; Adult; Anencephaly; Female; Heart Defects, Congenital; Hip Dislocation, Congenital; Humans; Hydrocephalus; Infant, Newborn; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Trimester, First; Spina Bifida Occulta | 1985 |